EntryPoint Capital »

Lexicon Pharmaceuticals shares owned by EntryPoint Capital

Quarter-by-quarter ownership of Lexicon Pharmaceuticals (LXRX) shares owned by EntryPoint Capital from 13F filings

Historical chart of EntryPoint Capital investment in Lexicon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lexicon Pharmaceuticals held by EntryPoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexicon Pharmaceuticals by EntryPoint Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $39k 34k 1.15

More positions owned by EntryPoint Capital

Charles Schwab Corporation (SCHW)
PNC Financial Services (PNC)
Ameriprise Financial (AMP)
Target Corporation (TGT)
Ares Management Corporation Cl A Com Stk (ARES)
UMH Properties (UMH)
Vici Pptys (VICI)
TJX Companies (TJX)
Service Corporation International (SCI)
Zoetis Cl A (ZTS)
Honeywell International (HON)
State Street Corporation (STT)
Marsh & McLennan Companies
News Corp Cl A (NWSA)
RBC Bearings Incorporated (RBC)

View all positions for EntryPoint Capital

Top funds holding Lexicon Pharmaceuticals

Artal Group
Siren
FMR
Vanguard Group
Millennium Management
BlackRock
UBS Group
Sessa Capital IM
Geode Capital Management
Citadel Advisors
Atlantic Trust
Jane Street
Susquehanna International
Marshall Wace
Charles Schwab Investment Management

View all funds holding Lexicon Pharmaceuticals